🔥 Trending Stocks
Most discussed tickers on social platforms within the R3K universe.
| Rank | Company | Close Price | Day Change | After-Hours Quote | Sentiment | Earnings |
|---|---|---|---|---|---|---|
| 1 |  CELH Celsius Holdings Inc | $29.21 | -0.48% | — | neutral | — |
| 2 |  CRMD CorMedix Inc | $7.53 | +0.53% | — | neutral | — |
| 3 |  ALMU Aeluma Inc | $16.20 | +5.68% | — | bullish | — |
| 4 |  ROOT Root Inc | $54.15 | -6.70% | — | bearish | — |
| 5 |  JNJ Johnson & Johnson | $256.35 | +0.21% | — | neutral | — |
| 6 |  REPL Replimune Group Inc | $11.20 | +107.02% | — | bullish | — |
| 7 |  LLY Lilly(Eli) & Co | $1148.50 | -0.56% | — | neutral | — |
| 8 |  QBTS D-Wave Quantum Inc | $18.08 | +0.56% | — | neutral | — |
| 9 |  UUUU Energy Fuels Inc | $11.44 | -2.31% | — | bearish | — |
| 10 |  SEZL Sezzle Inc. | $154.75 | -0.23% | — | neutral | — |
| 11 |  DUOL Duolingo Inc | $134.81 | +0.91% | — | neutral | — |
| 12 |  OMER Omeros Corp | $11.84 | -0.75% | — | neutral | — |
"Investors are closely monitoring Celsius Holdings as short interest remains elevated ahead of upcoming second-quarter earnings, with the community debating whether current price levels represent an undervalued entry point or a broader fundamental decline. Despite ongoing volatility and bearish sentiment regarding competition and margin pressure, bulls are actively accumulating shares and highlighting strong brand growth as potential catalysts for a reversal."
"CorMedix is seeing increased community chatter as investors digest recent institutional accumulation and corporate restructuring, even as the stock faces downward pressure from concerns over DefenCath's reimbursement transition. The community remains divided between long-term bulls highlighting strong institutional holdings and potential pipeline expansion, and skeptics wary of management's communication and recent performance trends."
"Aeluma Inc. is trending as investors rally around its selection for CHIPS Act funding and strategic semiconductor partnerships, which many in the community view as significant validation of its photonics technology. Discussion is heavily focused on a potential short squeeze, given high short interest, alongside excitement over recent executive hires and the company's long-term potential as a critical player in the AI data infrastructure supply chain."
"Root Inc. is trending as investors weigh an upcoming earnings report against community debate over the company's growth trajectory and the effectiveness of its AI-driven insurance model. Bullish sentiment centers on the company's improved profitability and expanding distribution partnerships, while skeptics emphasize concerns regarding stalled policy growth and the sustainability of marketing expense cuts."
"Johnson & Johnson is trending due to strong institutional interest and defensive sector rotation, as the company remains a top pick among analysts for its durable pharmaceutical pipeline and MedTech innovation despite lingering legal risks. Community discussions focus on the stock's stability during market volatility and its potential for long-term growth as capital shifts from high-beta tech into more established healthcare staples."
"Replimune Group is in the spotlight as investors debate the outcome of its upcoming FDA advisory committee meeting and PDUFA date for RP1. While the community is split between bullish sentiment over the potential for a breakthrough in refractory melanoma and bearish concerns stemming from repeated prior regulatory rejections and high put volume, discussion remains heavily focused on the clinical data integrity and the institutional-sized options flow suggesting a major move is imminent."